meperidine hydrochloride 10 MG/ML Oral Solution

What the CMS Formulary Data Shows for meperidine hydrochloride 10 MG/ML Oral Solution

Per the CMS 2026 Part D formulary file, meperidine hydrochloride 10 MG/ML Oral Solution (RxNorm concept RXCUI 861479, generic name meperidine hydrochloride) appears on 3 distinct formulary files spanning 65 Medicare Part D plan offerings - 1.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 2, with a cross-plan average of Tier 1.3.

Real-world access to meperidine hydrochloride 10 MG/ML Oral Solution depends on utilization management as much as tier placement: 66.7% of covering formularies require prior authorization. 0% require step therapy. 66.7% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 5,472 Part D beneficiaries filled meperidine hydrochloride 10 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $56,311 and an average per-beneficiary annual cost of $10.29. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry meperidine hydrochloride 10 MG/ML Oral Solution today.